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CObjective: Patients treated with an extensive approach including total aortic arch replacement for acute aortic
dissection type Amay have a favorable long-term prognosis by treating the residual false lumen. Our goal was to
analyze the operative strategy for treatment of type I DeBakey aortic dissection from the German Registry for
Acute Aortic Dissection Type A (GERAADA) data.
Methods: A total of 658 patients with type I DeBakey aortic dissection and entry only in the ascending aorta
were identified in the GERAADA. Patients in group A underwent replacement of the ascending aorta with hemi-
arch replacement. Patients in group B received extensive treatment with total arch replacement or conventional
or frozen elephant trunk.
Results:A total of 518 patients in group A and 140 patients in group Bwere treated. There was an overall 30-day
mortality of 20.2% (n ¼ 133). Group A had a slightly lower rate of mortality with 18.7% (n ¼ 97) compared
with 25.7% for group B (n ¼ 36), but with no statistical significant difference (P ¼ .067). The onset of new
neurologic deficit (13.6% in group vs 12.5% in group B, P¼ .78) and new malperfusion deficit (8.4% in group
A vs 10.7% in group B, P ¼ .53) showed no statistical difference.
Conclusions: On analysis of the GERAADA data, it seems that a more aggressive approach of aortic arch
treatment can be applied without higher perioperative risk even in the onset of acute aortic dissection type A.
Long-term follow-up data analysis will be necessary to offer the optimal surgical strategy for different patient
groups. (J Thorac Cardiovasc Surg 2012;144:617-23)Acute aortic dissection type A (AADA) remains a challeng-
ing condition to manage. Despite improvements in preoper-
ative diagnosis, surgical technique, and patient care, early
mortality and morbidity remain high.1 Conventional treat-
ment for acute dissection is replacement of the ascending
aorta often combined with a hemiarch replacement; how-
ever, this treatment leaves the downstream aorta untouched,
and a residually dissected aorta has been demonstrated in up
to 70% of patients.2-6 Because the residual dissection of the
descending aorta carries the risk of progressive aneurysmal
dilation,7 subsequent aortic reintervention of the descend-
ing aorta may be necessary, influencing the long-term ben-
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The Journal of Thoracic and Catreatment with total arch repair, possibly with adjunct
therapy of the descending aorta obliterating the false
lumen, is propagated by several groups to decrease the
incidence of late aortic complications.11-13 However, other
groups have demonstrated an increased risk of morbidity
and mortality with extensive surgery of the downstream
aorta, thus recommending a more conservative strategy
limited to the ascending aorta and proximal arch.14-16
The German Registry for Acute Aortic Dissection Type
A (GERAADA) is a web-based registry, initiated by the
Working Group for Aortic Surgery and Interventional Vas-
cular Surgery of the German Society for Thoracic and Car-
diovascular Surgery. The GERAADA is presently the
largest registry worldwide documenting patients undergo-
ing surgery for AADA.17-20 Analysis of the GERAADA
gave us the opportunity to perform large cohort analyses
of patients treated for DeBakey type I aortic dissection to
compare the surgical outcome of patients treated by total
arch replacement with those of hemiarch replacement
with respect to early mortality and onset of new
neurologic and malperfusion deficit.
MATERIALS AND METHODS
Patients
We analyzed all patients with AADA enrolled between July 2006 and
June 2010 in the GERAADA. The structure of this web-based registry hasrdiovascular Surgery c Volume 144, Number 3 617
Abbreviations and Acronyms
AADA ¼ acute aortic dissection type A
FET ¼ frozen elephant trunk
GERAADA ¼ German Registry for Acute Aortic
Dissection Type A
ICU ¼ intensive care unit
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Dbeen described.17,18 All patients with DeBakey type I aortic dissection were
included, that is, a dissection of the ascending aorta extending over the aortic
arch and involving the descending aorta. The localizationof the intimal entry
tear had to be limited to the ascending aorta. Patients demonstrating a tear
(entry or reentry) of the transverse arch requiring a total or subtotal arch
replacement were excluded from this cohort analysis. These patients were
then divided into 2 groups. Group A had conventional treatment with
replacement of the ascending aorta performed resecting the intimal tear. If
necessary, treatment of the aortic valve was performed by valve
resuspension, root reconstruction, or valve replacement. Hemiarch
replacement was performed in a period of circulatory arrest with an open
distal anastomosis. Group B had a more extensive surgery performed with
total arch replacement, possibly in combination with an elephant trunk or
frozen elephant trunk (FET) procedure.
Definition
Total arch replacement was defined as involving the total aortic arch
with reimplantation of the supra-aortic vessels as an island or as individual
branch grafts. Hemiarch replacement included the aortic arch beyond the
level of the innominate artery with or without reimplantation of the arch
vessels.
Neurologic deficit was defined as the presence of stroke, hemiparesis,
paraparesis, aphasia, or coma. Malperfusion deficit was defined as signs at-
tributable to disturbed blood flow to end-organ systems, such as myocar-
dial, visceral, or peripheral limb malperfusion. Excessive bleeding was
defined as more than 1000 mL over the initial 24-hour period.
Data Collection
Data were acquired by use of a standard online questionnaire developed
by the GERAADA principal investigator. Data collected included patient
demographics, preoperative and intraoperative status, postoperative com-
plications, early results, and date of death. Data forms were delivered to
the registry on the German Society for Thoracic and Cardiovascular Sur-
gery homepage (available at: http://www.dgthg.de).
Statistical Analysis
Statistics are summarized as frequencies and percentages for categoric
variables and as mean and standard deviation for continuous variables. Dif-
ferences in baseline characteristics between patients who underwent total
arch replacement or hemiarch replacement were compared using the
t test or the Mann–Whitney U test for continuous variables and the chi-
square test or Fisher exact test for categoric variables as appropriate. The
descriptive statistics and tests have been analyzed referring to cases without
missing values (complete case analysis). Influence of risk factors onto 30-
day mortality, new neurologic deficit, and new malperfusion deficit were
analyzed using logistic regression analysis. These factors included age;
presence of aortic aneurysm; clinical presentation, such as necessary ino-
trope medication, preoperative cardiopulmonary resuscitation, pericardial
tamponade, preoperative neurologic deficit, and preoperative malperfusion
deficit; gender; and operative data, such as length of cardiopulmonary by-
pass, aortic clamp time, length of circulatory arrest, and cerebral perfusion.618 The Journal of Thoracic and Cardiovascular SurgRESULTS
Between July 2006 and June 2010, 50 centers participat-
ing in the GERAADA reported on 2137 patients. From this
complete patient cohort, a subgroup of 658 patients was
identified with a DeBakey type I aortic dissection and entry
limited to the ascending aorta. All patients with an entry or
reentry in the transverse arch or proximal descending aorta
were excluded from the study. A total of 518 patients had
replacement of the ascending aorta performed with a hemi-
arch replacement, and 140 patients had a more extensive
and radical approach with total arch replacement, some
with treatment of the descending aorta with the elephant
trunk or FET procedure. Table 1 describes patient demo-
graphics, cause, clinical presentation, and imaging of pa-
tients with AADA. A total of 172 patients presented with
an existing neurologic deficit preoperatively (26.1%; group
A, 24.7% vs group B, 31.4%), and 261 patients presented
with a preoperative malperfusion deficit (39.7%; group A,
38.2% vs group B, 46.4%).
The mean age of group Awas 59.1  13.3 years, similar
to group B with a mean age of 58.3  11.9 years. In group
A, 62.6% were male, and in group B, 61.4% were male.
Connective tissue disorders were rare, most patients pre-
sented with arterial hypertension, 26.5% of group A had
an aortic aneurysm, 35.7% of group B presented with an
aortic aneurysm (P¼ .03). Patients in group B had a higher
frequency of cardiopulmonary resuscitation (P ¼ .04); oth-
erwise, the patients presented with relatively similar clinical
conditions. Most patients were diagnosed by computed to-
mography and echocardiography; significantly more pa-
tients in group B had a diagnosis performed by
echocardiography (P ¼ .007) and angiography (P ¼ .014).
All patients underwent surgery via a median sternotomy
and cardiopulmonary bypass. The operative procedure was
significantly shorter with hemiarch replacement (318.1 
104.4 minutes) than with total arch replacement (390.4 
137.3 min, P<.001), and themean time of circulatory arrest
was shorter for group A than for group B (24.3  14.4 min-
utes vs 44.8  29.7 minutes, P<.001). Further details are
demonstrated in Table 2. The postoperative outcome
showed a higher rate of rethoracotomy for group B
(18.5% vs 28.6%, P ¼ .013) and a higher rate of bleeding
(22.3% vs 35.7%, P¼ .002). In group B, the postoperative
intensive care unit (ICU) length of stay was longer (8.1 
11.3 days vs 10.3  13.8 days, P<.001) and the hospital
stay was longer (16.3  14.6 days vs 17.1  16.1 days,
P<.001).
The onset of new neurologic deficit showed no difference
between the 2 groups (13.6% vs 12.5%, P ¼ .78). Patients
with a preexisting neurologic deficit (n ¼ 128 in group A
and n ¼ 44 in group B) were excluded from this analysis.
The preoperative neurologic condition showed no influence
on the type of surgery performed (24.7% vs 31.4%,ery c September 2012
TABLE 1. Demographics, cause, clinical presentation, and diagnostic
imaging
Variable
Group A
n ¼ 518
Group B
n ¼ 140 P
Clinical characteristics
Age (y) 59.1  13.3 58.3  11.9
Gender: male 324 (62.6%) 86 (61.4%) .84
Cause
Arterial hypertension 283 (54.6%) 88 (62.9%) .08
Aortic aneurysm 137 (26.5%) 50 (35.7%) .03
Clinical presentation
Cardiac tamponade 101 (19.5%) 36 (25.7%) .12
Cardiopulmonary resuscitation 26 (5.1%) 14 (10%) .04
Intubated by admission 87 (16.8%) 23 (16.4%) 1
Hemiplegia or hemiparesis 50 (9.7%) 14 (10%) .87
Paraplegia or paraparesis 24 (4.63%) 12 (8.6%) .09
Aphasia 13 (2.5%) 2 (1.4%) .74
Diagnostic imaging
Computed tomography 465 (89.8%) 123 (87.7%) .54
Echocardiography 232 (44.8%) 81 (57.9%) .007
Angiography 35 (6.7%) 19 (13.6%) .014
Magnetic resonance 11 (2.1%) 4 (2.9%) .53
TABLE 2. Surgical procedure and early postoperative outcome
Variable
Group A
n ¼ 518
Group B
n ¼ 140 P
Surgical procedures
Mean operative time (min) 318.1  104.4 390.4  137.3 <.001
Mean circulatory arrest time
(min)
24.3  14.4 44.8  29.7 <.001
Degree of hypothermia (C) 23.1  4.1 23  3.8
Selective cerebral perfusion 347 (67%) 118 (84.2%) <.001
Ascending aortic
replacement
367 (70.9%) 89 (63.6%) .09
Composite graft replacement 110 (21.2%) 39 (27.9%) .11
David operation 33 (6.4%) 12 (8.6%) .34
Yacoub operation 10 (1.9%) 5 (3.6%) .33
Elephant trunk 0 48 (34.3) <.001
CABG 49 (9.5%) 15 (10.7%) .63
Valve replacement/repair 113 (21.8%) 41 (29.2%) .07
Outcome
Rethoracotomy 96 (18.5%) 40 (28.6%) .013
Bleeding (>1000 mL) 116 (22.3%) 50 (35.7%) .002
New incidence of neurology 53 (13.6%) 12 (12.5%) .78
New incidence of
malperfusion
27 (8.4%) 8 (10.7%) .53
ICU length of stay (d) 8.1  11.3 10.3  13.8 <.001
Hospital length of stay (d) 16.3  14.6 17.1  16.1 <.001
CABG, Coronary artery bypass grafting.
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DP ¼ .11). The presence of preoperative neurologic deficit
showed no difference in postoperative mortality (32.8%
vs 29.5%, P¼ .69); however, if patients underwent surgery
without a preexisting neurologic deficit, group A demon-
strated a lower risk of mortality than group B with the
more extensive procedure (14.1% vs 24%, P ¼ .02).
A McNemar’s test was performed investigating the influ-
ence of surgical procedure on the reduction of existing pre-
operative neurologic deficits; however, there were no
significant differences to be seen.
Likewise, the analysis was performed for malperfusion.
The onset of newmalperfusion showed no significant differ-
ence (8.4% vs 10.7%, P ¼ .53). Postoperative mortality in
patients with preoperative malperfusion was similar
(25.5% vs 33.8%, P ¼ .19); in the absence of preoperative
malperfusion, there was no significant difference (14.6% vs
18.7%, P ¼ .37)
Overall mortality was 133 patients (20.2%), with a ten-
dency to a lower rate of mortality in group A (18.7%)
than in group B (25.7%), but without significant statistical
difference (P ¼ .07).
Logistic regression analysis of clinical presentation and
surgery on 30-day mortality showed age (P ¼ .0072), pre-
operative resuscitation (P¼ .041), length of cerebral perfu-
sion (P¼ .0122), and length of circulatory arrest (P¼ .041)
to be significant risk factors for early postoperative mortal-
ity (Table 3). Regression analysis investigating the influ-
ence of the type of surgery chosen demonstrated more
extensive surgery with total arch replacement, but this
was not a significant risk factor for the 30-day mortality
(P ¼ .11). Logistic regression analysis of clinical presenta-
tion and surgery for the onset of new neurologic deficitThe Journal of Thoracic and Cashowed no significant risk factors (Table 3). A logistic re-
gression analysis for the onset of new malperfusion deficit
demonstrated aortic aneurysm (P ¼ .023), length of cere-
bral perfusion (P ¼ .0064), and length of circulatory arrest
(P ¼ .021) to be risk factors (Table 3).DISCUSSION
The long-term benefits of the surgical treatment for
AADA may be influenced by the presence of a patent false
lumen of the untreated descending aorta, seen in up to 70%
of patients treated for AADA.1 The residually dissected
downstream aorta has been shown to be a significant risk
factor for descending aortic aneurysm formation.7 Because
anastomotic leakage or small tears in the descending aorta
can exist after replacement of the ascending aorta or hemi-
arch, the false lumen is susceptible to dilation because of
shear stress acting on the proximal descending aorta.13 In
previous studies, aneurysmal dilation occurred in 15% to
60% within 10 years,2,5,6 and as many as 25% required
second surgery within 5 to 10 years.3,4,21
Several groups propagate a more extensive approach for
the treatment of AADA with total arch replacement to de-
crease the prevalence of a patent false lumen bymaximizing
the resection of entry tears.11,22-24 Kazui and colleagues11
reported subsequent dilation of the most susceptible parts
of the false lumen to be prevented when the descending
aorta was repaired up to the mid-portion using the elephant
trunk technique. The clinical data presented show excellentrdiovascular Surgery c Volume 144, Number 3 619
TABLE 3. Binary logistic regression analysis for 30-day mortality,
new neurologic deficit, and new malperfusion deficit
Variable OR 95% CI P
30-d mortality for all patients
Age* 1.05 1.01–1.08 .0072
Aortic aneurysm 0.74 0.32–1.72 .48
Preoperative resuscitation 4.99 1.07–23.20 .04
Preoperative inotrope medication 1.21 0.41–3.58 .74
Pericardial tamponade 2.12 0.8–5.65 .13
Gender 1.15 0.53–2.51 .71
Operative timey 1.01 0.99–1.01 .11
Cardiopulmonary bypass timey 1.01 0.99–1.01 .18
Aortic clamp timey 1.01 0.99–1.01 .69
Length of cerebral perfusiony 0.95 0.92–0.99 .01
Length of circulatory arresty 1.04 1.00–1.07 .04
Hemiarch replacement 0.49 0.20–1.2 .11
New neurologic deficit
Age* 1 0.97–1.03 .73
Aortic aneurysm 0.38 0.15–0.99 .05
Preoperative resuscitation 2.58 0.57–11.67 .22
Preoperative inotrope medication 1.36 0.47–3.95 .58
Pericardial tamponade 1.02 0.36–2.88 .97
Gender 1.29 0.63–2.66 .49
Operative timey 1.00 0.99–1.01 .54
Cardiopulmonary bypass timey 0.99 0.99–1.01 .62
Aortic clamp timey 1.0 0.99–1.01 .44
Length of cerebral perfusiony 1.0 0.98–1.02 .90
Length of circulatory arresty 0.99 0.97–1.02 .56
Hemiarch replacement 1.16 048.–2.79 .73
New malperfusion deficit
Age* 1.02 0.99–1.06 .24
Aortic aneurysm 0.26 0.083–0.084 .02
Preoperative resuscitation 3.75 0.59–23.96 .16
Preoperative inotrope medication 0.59 0.15–2.27 .43
Pericardial tamponade 3.03 0.99–9.26 .05
Gender 1.14 0.47–2.79 .77
Operative timey 1.01 1.00–1.01 .10
Cardiopulmonary bypass timey 1.0 1.00–1.01 .33
Aortic clamp timey 0.99 0.98–1.0 .06
Length of cerebral perfusiony 0.93 0.88–0.98 .006
Length of circulatory arresty 1.06 1.01–1.12 .02
Hemiarch replacement 0.3 0.10–0.86 .02
OR, Odds ratio; CI, confidence interval. *OR calculated over a 5-year time interval.
yOR calculated over 60-minute time intervals.
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Doperative results with a low rate of mortality. Patients who
underwent total arch replacement showed a more favorable
outcome in terms of progressive aortic enlargement than
those with only ascending aorta and hemiarch replace-
ment.13 Other surgeons advocated insertion of a small ele-
phant trunk during replacement of the aortic arch to
exclude small intimal tears adjacent to the anastomosis.25
Complete thrombosis of the false lumen in the proximal de-
scending aorta was achieved in 43.2% of patients at dis-
charge and in 100% of patients at 3 years after treatment
for AAD surgery.26620 The Journal of Thoracic and Cardiovascular SurgSeveral groups propagate an even more aggressive treat-
ment in the setting of AADA, with an antegrade stenting of
the descending aorta over the open aortic arch in circulatory
arrest using the FET technique. Uchida and colleagues13
performed the FET procedure in patients aged less than
70 years with AADA and obtained good long-term results;
the procedure was also selected for patients with a narrow-
ing of the true lumen, which may lead tomalperfusion of the
visceral branches.13 In-hospital mortality for the FET tech-
nique was excellent at 4.6%. Long-term results demon-
strated a survival of 95.3% at 5 years and an event-free
rate of 95.7% at 5 years compared with 73.0% for patients
with hemiarch replacement for AADA. Tsagakis and col-
leagues27 also demonstrated good operative results with
an in-hospital mortality of 12% and 92% immediate false
lumen thrombosis in the perigraft stent level for AADA
with the use of the Evita Open prosthesis.27
These results encourage the more extensive and radical
approach for treatment for AADA, but at the cost of
a more invasive and complicated surgical procedure. The
longer periods of myocardial ischemia and circulatory ar-
rest are inevitable in extensive arch surgery directly related
to cardiac and cerebral injuries, as well as organ dysfunc-
tion. Concomitant distal aortic arch manipulation has
been demonstrated to increase the risk of mortality andmor-
bidity by several groups.14-16 Furthermore, various studies
have documented the natural course of the dissected
descending aorta after AADA. Sabik and colleagues28
showed that the residual dissected aorta did not decrease
late survival and demonstrated a low risk of aneurysmal
change and reoperations for at least 10 years. Crawford
and colleagues14 showed 70% of surviving patients with
DeBakey type I dissection did not have a second aortic op-
eration for aneurysmal dilation of the distal false channel,
but this did not include the patients in whom an intimal
tear in the transverse aortic arch was included in the resec-
tion. Dobrilovic and Elefteriades29 demonstrated a need for
reoperation in only 2% of patients for dilation of the de-
scending aorta after analysis of the Yale Center for Thoracic
Aortic Disease database, with a growth rate of only 0.28 cm
per year. Kim and colleagues30 recently described a poorer
survival and neurologic outcome for patients with total arch
replacement. In their study, the rate of reoperation was not
affected by the type of surgery for AADA, and the reopera-
tions were performed without significant mortality or
morbidity.
It is clear that the controversial data setting confuses
choosing the optimal therapeutic regimen for treatment of
this life-threatening disease. Clinical studies to date have
limitations with small patient groups and biased patient se-
lection influencing postoperative results and their interpre-
tation. Use of the GERAADA, the largest worldwide
registry for the treatment of AADA, allowed us to analyze
a large patient cohort focusing on the influence of theery c September 2012
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Doperative strategy chosen for the aortic arch and its influ-
ence on mortality, as well as the onset of new neurologic
and malperfusion deficit.
Postoperative mortality was 20.2% for patients with De-
Bakey type I dissection in the GERAADA. A tendency for
lower postoperative mortality in those receiving hemiarch
replacement compared with total arch replacement
(18.7% vs 25.7%) fails to be statistically significant; how-
ever, the less aggressive procedure is favored. The analysis
investigating intra- and postoperative data shows results
comparable to data provided by other groups investigating
outcomes after surgery for AADA.31 Patients treated for
AADA often have a complicated postoperative recovery;
age, renal failure, prolonged hypothermic circulatory arrest,
and postoperative pulmonary dysfunction are some of the
risk factors for prolonged ICU stay and predictors of mor-
tality.32 This may be a reason for the relatively long period
of re-convalescence, reflected by the long period of ICU and
hospital stays. Higher rates of rethoracotomy (P ¼ .013)
and excessive bleeding (>1000 mL/d) (P ¼ .002) demon-
strate the postoperative complications caused by the coagu-
lopathic disorders induced by hypothermia and influence
the length of ICU and hospital stays.
Cerebral perfusion deficit has been demonstrated to be
a major risk factor in AADA32-34 and is often a reason for
delaying surgical repair. The onset of new neurologic
deficit shows no difference between the hemiarch and
total arch groups (13.6% vs 12.5%, P ¼ .78), unlike the
findings of Kim and colleagues30 of more frequent neuro-
logic dysfunction in patients receiving total arch replace-
ment. Overall onset of neurologic dysfunction is similar
to that in other reports, with 13.4% after surgery. Uchida
and colleagues13 described excellent results with no new ce-
rebral deficits and spinal cord injury postoperatively. The
GERAADA, with 50 heart centers with different experience
in aortic surgery involved, could not reproduce such results.
Kim and colleagues30 describe complications with new on-
set of neurologic dysfunction in 31.4%, and Kallenbach
and colleagues35 demonstrated neurologic complications
in 22% of 295 patients treated for AADA in Hannover. Fur-
ther analysis was performed on what influence the preoper-
ative neurologic status had on the decision on type of
surgery. The rationale behind this analysis is a simple algo-
rithmic decision. Did the complex situation with existing
preoperative neurologic impairment, such as hemiparesis,
paraparesis, aphasia, or coma, prompt the surgeon to choose
a quicker and less-invasive procedure with less anticipated
perioperative and early postoperative complications? Even
here no difference was seen, with 24.7% with preoperative
neurologic deficit in group A and 31.4% operated in group
B (P ¼ .11).
End-organ malperfusion and ischemia develop in 16% to
30% of patients with AADA,36-40 resulting in
a postoperative mortality of up to 89% in patients withThe Journal of Thoracic and Caa preexisting malperfusion pathology.39 Prolonged end-
organ ischemia induces a rapid inflammatory cascade,
which increases the operative risk dramatically. Different
operative strategies have been developed to address this pre-
operative risk constellation, such as dissection membrane
fenestration with subsequent surgical repair after the in-
flammatory cascade subsides. However, this delays treat-
ment of the dissected aorta, increasing the risk of aortic
rupture or dissection-related complications.41 Other groups
propagate immediate surgical treatment of the dissected
aorta with the rationale of restoring perfusion over the
true lumen and thus resolving a major group of malperfu-
sion pathology. Fann and colleagues38 demonstrated only
a minority of patients requiring additional procedures after
central aortic repair and a similar rate of mortality in the
presence or absence of malperfusion before surgical
treatment. The prognosis of patients with preoperative mal-
perfusion remains poor, and prolonged periods of cardio-
pulmonary bypass and large volume blood resuscitation
may contribute to a large capillary leak and end-organ dam-
age.36 In view of the patient analysis, 39.7% of patients pre-
sented with a malperfusion deficit, including coronary,
spinal, visceral, or peripheral limb ischemia. There was
no difference in the onset of new malperfusion deficit after
surgical treatment between the 2 groups (P ¼ .53).
CONCLUSIONS
On analysis of the GERAADA data, it may be concluded
that the more extensive treatment with total arch replace-
ment and possibly adjunct therapy of the descending aorta
can be performed in patients with AADA at an acceptable
operative risk comparable to the standard treatment with re-
placement of the ascending aorta. Immediate postoperative
complications, such as excessive bleeding and frequency of
rethoracotomy, are higher; however, the 30-day mortality
and onset of new neurologic and malperfusion deficit
showed no significant difference. In the absence of preexist-
ing neurologic deficits, subgroup analysis demonstrates
a higher mortality for patients treated with total arch
replacement.
Study Limitations
Limitations of the study are clear; factors such as case
volume per center, experience of the individual surgeon,
aortic wall quality, and institutional philosophy influence
the decision for method of treatment and cannot be taken
into account in this analysis. The goal of this registry anal-
ysis is not to propagate or criticize a more radical aortic arch
approach of treatment for AADA. A more conservative sur-
gical treatment of AADA without aortic arch replacement
allows consistently good operative results when performed
by experienced surgeons. Total arch replacement may con-
tribute to a positive outcome of the proximal descending
aorta, but the distal descending aorta and abdominal aortardiovascular Surgery c Volume 144, Number 3 621
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Dmay still be prone to aneurysmal dilation. Long-term results
are presently not obtained by the registry data, which are
clearly necessary to justify the necessity of possible aortic
reintervention for patients treated for AADA by the differ-
ing surgical approaches. Modifications of the GERAADA
address this issue with yearly follow-up data up to 10 years
after surgery included for a more thorough analysis of pa-
tients with AADA.
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